Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2010
07/21/2010CN101278951B Chinese chestnut health care capsule
07/21/2010CN101077386B Traditional Chinese medicine composition for treating allergic purpura
07/21/2010CN101077183B Novel capilary artemisia red date composite health care beverage and its processing technology
07/21/2010CN101007011B Ginsenoside Rh2 self-emulsifying composition and its preparation method
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
07/20/2010US7759364 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
07/20/2010US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis
07/20/2010US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
07/20/2010US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
07/20/2010US7759323 Highly purified antiendotoxin compound
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2410586C Recombinant or purified polyclonal antibodies for treating allergy
07/20/2010CA2197563C Capsular polysaccharide immunomodulator
07/20/2010CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
07/15/2010WO2010080577A2 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation
07/15/2010WO2010080481A1 Carbazole carboxamide compounds useful as kinase inhibitors
07/15/2010WO2010080409A1 Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid
07/15/2010WO2010080188A2 Epitope targeted anthrax vaccine
07/15/2010WO2010080007A2 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
07/15/2010WO2010079668A1 Olefin compound
07/15/2010WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
07/15/2010WO2010078711A1 Amino methanol derivants and salts thereof and their preparation methods and medical use
07/15/2010WO2010042644A3 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines
07/15/2010WO2010037765A3 4 -morpholino-pyrido [3, 2 -d] pyrimidines active on pi3k
07/15/2010WO2009146034A3 Mapk/erk kinase inhibitors and methods of use thereof
07/15/2010WO2009103727A3 Combination of an iron chelator and an immunosuppressant and use thereof
07/15/2010WO2009074247A8 Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
07/15/2010US20100179304 Somatostatin-Dopamine Chimeric analogs
07/15/2010US20100179216 Amine compound and pharmaceutical use thereof
07/15/2010US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
07/15/2010US20100179182 Pharmaceutical formulation
07/15/2010US20100179177 Heterocyclic compounds and their uses
07/15/2010US20100179153 Bicyclic S1P Receptor Modulators
07/15/2010US20100179146 Indolinone Compounds as Kinase Inhibitors
07/15/2010US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors
07/15/2010US20100179126 Thiolactams and uses thereof
07/15/2010US20100179124 Thieno-pyridine derivatives as mek inhibitors
07/15/2010US20100179123 Thienopyrimidines useful as aurora kinase inhibitors
07/15/2010US20100179118 Cyclic aminoalkylcarboxamide derivative
07/15/2010US20100179104 Synthetic nutritional formulations
07/15/2010US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases
07/15/2010US20100179100 Medicinal forms of phospholipid preparations and methods for their preparation
07/15/2010US20100178368 Plant extract and its therapeutic use
07/15/2010US20100178364 Dietary supplements against latent foreign DNA
07/15/2010US20100178354 Remedy
07/15/2010US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
07/15/2010US20100178337 Composition comprising an active agent with low aqueous solubility
07/15/2010US20100178303 Stable organic-carrier-based microbial inoculants and method for producing the same
07/15/2010US20100178301 Method of treating pregnant cows and/or heifers
07/15/2010US20100178296 Antibodies to cd200r
07/15/2010US20100178288 Use of aphanamixis polystacha extracts or fractions against 5-lipoxygenase mediated diseases
07/15/2010US20100178275 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
07/15/2010US20100178272 Structure and use of 5'phosphate oligonucleotides
07/15/2010CA2747670A1 Carbazole carboxamide compounds useful as kinase inhibitors
07/15/2010CA2747437A1 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid
07/14/2010EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles
07/14/2010EP2206776A1 Mite antigenic rice
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206710A1 Indole derivatives as S1P1 receptor agonists
07/14/2010EP2206702A1 Bicyclic compound, production and use thereof
07/14/2010EP2206534A1 Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds
07/14/2010EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies
07/14/2010EP2206511A1 Protein a compositions and methods of use
07/14/2010EP2206502A1 Polymer conjugate of steroid
07/14/2010EP2205640A2 Antibodies that bind il-4 and/or il-13 and their uses
07/14/2010EP2205588A2 Oxypiperidine derivatives as histamine receptor antagonists
07/14/2010EP2205585A1 Quinoline derivatives used to treat inflammatory and allergic diseases
07/14/2010EP2205269A1 Therapeutic uses of intermedin 47 and 53 peptides
07/14/2010EP2205259A1 Method of regulating the th17 pathway and its associated metabolic impact
07/14/2010EP2205241A1 Polo-like kinase inhibitors
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon
07/14/2010EP1203587B1 A medicament and method for the production thereof
07/14/2010CN1935235B Chinese medicine injection preparation and its preparing method
07/14/2010CN101775360A Preparation method of Bacillus licheniformis and raw pesticide
07/14/2010CN101775078A Sea urchin content polysaccharide having anti-tumor and immunological activities and preparation method
07/14/2010CN101775023A Isoflavone lignanoid compound extracted from camel thorn plants, as well as application and extraction method thereof
07/14/2010CN101773606A Preparation capable of nursing essence, replenishing qi, refreshing spirit and balancing yin and yang and preparation method thereof
07/14/2010CN101773592A Method fro controlling quality of pill of six ingredients with rehmannia
07/14/2010CN101773548A Pharmaceutical composition for improving immunity
07/14/2010CN101773541A Yupingfeng soft capsule
07/14/2010CN101773526A Production technology of ganoderma lucidum spore powder
07/14/2010CN101773523A Traditional Chinese medicine antimanic drug for treatment of hyperlipemia and preparation thereof
07/14/2010CN101773521A Method for purifying deer serum
07/14/2010CN101773517A H2S or H2S donator temperature sensitivity instant gel preparation for injection
07/14/2010CN101773509A Glycyrrhizin high-concentration preparation
07/14/2010CN101773503A Leukotriene antagonist and antihistaminics composition
07/14/2010CN101773494A New application of green tea polyphenol
07/14/2010CN101773493A New application of medicine compound brazilein
07/14/2010CN101336653B Biscuit formulation capable of enhancing immunity and preparation method thereof
07/14/2010CN101129473B Radix fici simplicissimatis extractive and method of producing the same and use thereof
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1172